Peters S, Danson S, Ejedepang D, Dafni U, et al. Combined, patient-level, analysis of two randomised trials evaluating the addition of denosumab to standard first-line chemotherapy in advanced NSCLC - The ETOP/EORTC SPLENDOUR and AMGEN-249 trials. Lung Cancer 2021;161:76-85.
PMID: 34543941